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In Brief
Maf1 is an evolutionarily conserved
repressor of RNA polymerase III
transcription that has been well
characterized in single-cell models. The
function of mafr-1 in the context of a
multicellular organism, however, is not
well understood. In this study, Khanna
et al. identifymafr-1 as central node in the
maintenance of C. elegans physiological
homeostasis, where it functions as a
potent regulator of reproduction and lipid
homeostasis.
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Maf1 is a conserved repressor of RNA polymerase
(Pol) III transcription; however, its physiological role
in the context of a multicellular organism is not well
understood. Here, we show that C. elegans MAFR-1
is functionally orthologous to humanMaf1, represses
the expression of both RNA Pol III and Pol II tran-
scripts, and mediates organismal fecundity and lipid
homeostasis. MAFR-1 impacts lipid transport by
modulating intestinal expression of the vitellogenin
family of proteins, resulting in cell-nonautonomous
defects in the developing reproductive system.
MAFR-1 levels inversely correlate with stored intesti-
nal lipids, in part by influencing the expression of the
lipogenesis enzymes fasn-1/FASN and pod-2/ACC1.
Animals fed a high carbohydrate diet exhibit reduced
mafr-1 expression and mutations in the insulin
signaling pathway genes daf-18/PTEN and daf-16/
FoxO abrogate the lipid storage defects associated
with deregulated mafr-1 expression. Our results
reveal physiological roles for mafr-1 in regulating
organismal lipid homeostasis, which ensure repro-
ductive success.INTRODUCTION
Initially characterized in S. cerevisiae, Maf1 is an evolutionarily
conserved transcriptional corepressor of RNA polymerase (Pol)
III-dependent genes, such as tRNA and 5S rRNA, which impact
the biosynthetic capacity of the cell (Upadhya et al., 2002; Van-
nini et al., 2010). This function of Maf1 is conserved, as human,
mouse, and Drosophila Maf1 also represses tRNA transcription
(Boguta, 2013; Boguta and Graczyk, 2011; Marshall et al.,
2012; Rideout et al., 2012). Mammalian Maf1 additionally regu-
lates certain RNA Pol II-dependent promoters, including some
Elk-1-regulated genes (Johnson et al., 2007). Given that Maf1
has extended roles in higher eukaryotes, we examined its func-
tion in a physiological context.2180 Cell Reports 9, 2180–2191, December 24, 2014 ª2014 The AutWe were keen to investigate the physiological role of Maf1
in a genetically tractable system such as C. elegans. We exam-
ined the function of the related C. elegans MAF polymerase III
Regulator-1 (MAFR-1) protein and elucidated the functional
consequences of altered mafr-1 expression on development,
reproduction, and lipid homeostasis. In C. elegans, metabolic
homeostasis is maintained by multiple evolutionarily conserved
mechanisms (Barros et al., 2012; Brey et al., 2009; Brock et al.,
2006, 2007; O’Rourke et al., 2009; Paek et al., 2012; Soukas
et al., 2009; Walker et al., 2011; Watts, 2009; Zheng and
Greenway, 2012), and C. elegans has become exceptionally
useful for high-throughput screening studies of complex cellular
processes relevant to human diseases (Anastassopoulou et al.,
2011; Squiban et al., 2012; Wa¨hlby et al., 2012). We have discov-
ered that MAFR-1 negatively regulates intracellular lipid accu-
mulation and influences reproductive capacity. Taken together,
these studies define the physiological roles for Maf1 and indicate
the potential for targeting of Maf1 for therapeutic strategies for
the prevention and treatment of metabolic diseases with deregu-
lated lipid phenotypes.RESULTS
C. elegansMAFR-1 Is a ConservedModulator of RNA Pol
III and Pol II Transcript Levels
Given the conserved role of Maf1 as a negative regulator of RNA
Pol III in yeast, flies, and mammals, we investigated whether
C. elegans MAFR-1 functions in an orthologous manner. We
reducedmafr-1 expression by RNAi andmeasured the transcript
levels of established RNA Pol III transcripts, such as tRNAs. As
predicted, when mafr-1 expression was reduced by approxi-
mately 50% (Figure S1A), the expression of most tRNAs were
significantly increased as compared to the internal normalization
control, snb-1, whose expression was stable (Figures 1A and
S1A). We further examined animals harboring an additional chro-
mosomally integrated copy of mafr-1, which results in a 80%
increase in mafr-1 overexpression (mafr-1 O/E) (Figure S1B)
and observed a striking reduction in all tRNAs tested (Figures
1B and S1B). Furthermore, the reduction of tRNA levels
observed in mafr-1 O/E animals was restored when animals
were fed dsRNA targeting mafr-1, indicating that the effectshors
Figure 1. MAFR-1 Is a Conserved Modulator of RNA Pol III and RNA Pol II
(A and B) Expression of RNA Pol III targets in mafr-1 RNAi-treated animals (A) or animals overexpressing (O/E) mafr-1 (B).
(C) Expression of human RNA Pol III targets in 293T cells transfected with mafr-1 or Maf1.
(D) Expression of the RNA Pol II target tbp-1/TBP.
(E and F) Developmental expression pattern of mafr-1 mRNA (E) and MAFR-1::GFP protein (F).
(G–I) MAFR-1 tissue expression revealed by imaging animals expressing MAFR-1::GFP DIC (G) (A, anterior and P, posterior), intestinal cells (H) (arrows), and
hypodermal cells (I) (arrowheads).
Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 versus respective controls. Scale bars represent 100 mm. See also Figure S1.on RNA Pol III transcripts were specific to mafr-1 levels
(Figure S1C).
Drosophila dMaf1 was shown to control body size and devel-
opmental timing by specifically regulating tRNAi
Met synthesis
(Rideout et al., 2012). InC. elegans,mafr-1 expression is inversely
correlated with the synthesis of multiple tRNAs, including
tRNAi
Met (Figure 1A). mafr-1 RNAi increases animal body areaCell Reby 4%, whereasmafr-1 O/E leads to a 7% decrease in body
area (Figure S1D). Unlike modulation of dMaf1 in flies, mafr-1
levels do not alter developmental timing in theworm (Figure S1E).
We tested the ability of MAFR-1 to regulate the expression of
mammalian RNA Pol III targets. Overexpression of either MAFR-
1 or human Maf1 in human 293T cells was sufficient to reduce
the expression of multiple human RNA Pol III transcriptsports 9, 2180–2191, December 24, 2014 ª2014 The Authors 2181
Table 1. GO Term Analysis of 1,495 Genes Downregulated in
mafr-1 O/E Animals
GO Terma Enrichmentb
Developmental process
involved in reproduction
score = 24.51, p value = 10 3 1011
Reproductive structure
development
(% genes in group)
18.74
Germ cell development
(% genes in group)
19.44
Primary metabolic process score = 5.46, p value = 0.004
Amino acid metabolism
(% genes in group)
9.65
Lipid metabolism
(% genes in group)
9.09
Carbohydrate metabolism
(% genes in group)
8.29
Negative regulation of
translation
score = 5.18, p value = 0.005
Lipid transport score = 4.82, p value = 0.01
aPartek Genomic Suite used for microarray data set and GO enrichment
analysis fold change ± 2, false discovery rate % 0.001. GO, Gene
Ontology.
bFisher’s exact test was used for GO term enrichment.(Figure 1C). This indicates that C. elegans MAFR-1 function is
conserved across metazoans. Because humanMaf1 is recruited
to the promoters of select RNA Pol II genes, such as TBP1 (John-
son et al., 2007), we examined the ability of MAFR-1 to regulate
tbp-1. Similar to mammalian Maf1, MAFR-1 is also capable of
negatively regulating the expression of the RNA Pol II target
tbp-1 in worms as well as human TBP1 in 293T cells (Figure 1D).
One model for Maf1 function is as a transcriptional repressor by
interacting with components of the RNA Pol III-specific TFIIIB
complex, which contains RNA Pol III, Bdp1, Tbp1, and Brf1 (Bo-
guta, 2013; Boguta and Graczyk, 2011; Marshall et al., 2012).
Consistent with previous reports in other organisms, decreased
expression of tbp-1 or brf-1 in C. elegans effectively reduced the
expression of RNA Pol III transcripts, similar to mafr-1 O/E (Fig-
ures S1G and S1H). Importantly, RNAi of tbp-1 or brf-1 in the
mafr-1 O/E strain did not further reduce the expression of tRNAs
(Figure S1H), indicating that MAFR-1, TBP-1, and BRF-1 func-
tion in the same pathway to regulate RNA Pol III-dependent
transcription. Collectively, these results support a conserved
role for MAFR-1 as a negative regulator of both RNA Pol III-
and RNA Pol II-mediated transcription and identify MAFR-1 as
a functional ortholog of mammalian Maf1.
MAFR-1 Expression in C. elegans Fat Storage Tissues
Alters the Expression of Metabolism and Reproduction
Genes
To identify the physiological roles of MAFR-1 in a multicellular or-
ganism,wefirst examined the temporal expressionofmafr-1 tran-
scripts and MAFR-1::GFP protein throughout development and
documented the tissue expression patterns of MAFR-1::GFP.
mafr-1 expression is highest in embryos but is reduced after2182 Cell Reports 9, 2180–2191, December 24, 2014 ª2014 The Authatching and remains relatively constant throughout larval devel-
opment and into adulthood (Figure 1E). After embryogenesis, the
levels of MAFR-1 protein are reduced and stabilize (31 hr after
hatching) in the L3/L4 larval stage (Figure 1F). We next examined
the tissue expression pattern of MAFR-1 using transgenic ani-
mals expressing a MAFR-1::GFP fusion construct. We observed
the strongest expression of MAFR-1::GFP in the intestine and
hypodermis, which are the two major sites of fat storage in
C. elegans (Mak, 2012; O’Rourke et al., 2009) (Figures 1G–1I).
Our discovery that MAFR-1 can modulate the expression of
RNAPol II genes, such as tbp-1, fits previous reports of the local-
ization of human Maf1 at select RNA Pol II promoters (Johnson
et al., 2007). However, it remains unclear if worm MAFR-1
directly regulates these genes and the extent to which Maf1
can impact the expression of RNA Pol II transcriptional targets.
We therefore compared the steady state gene expression pro-
files of a single-copy mafr-1 O/E model to control animals. The
canonical role of MAFR-1 as a negative regulator of transcription
drove our analysis of genes whose expression was reduced
when mafr-1 was overexpressed (Table 1). A bioinformatic
examination of these genes identified enrichment for Gene
Ontology (GO) terms related to reproduction and metabolism
(Table 1). Enrichment for factors associated with the negative
regulation of translation and lipid transport were also identified.
GO terms linked to the regulation of RNA Pol III target expression
(4.17% of genes of this GO term were represented) and RNA po-
lymerase activity (5.26% of genes of this GO term were repre-
sented) were also identified (data not shown). We also identified
transcripts that were increased in themafr-1 O/E animals (Table
S1), whichmay represent homeostatic responses to deregulated
mafr-1 expression. These findings support a role for MAFR-1 in
modulating RNA Pol III, but also reveal its ability to influence
RNA Pol II targets with biological functions beyond protein syn-
thesis capacity. We investigated a selection of transcripts whose
expression was deregulated when mafr-1 levels are altered.
These transcripts were selected based on the degree and signif-
icance of the change and the identification of a representative
portion of the genes within the gene family or GO term group.
mafr-1 Negatively Regulates Lipid Transport and
Fecundity
Our analysis of the transcripts sensitive to mafr-1 expression
identified components of the C. elegans vitellogenin (vit) lipid
transport system, which were significantly downregulated
(20- to 50-fold as compared to wild-type) in our microarray
analysis (Figure 2A). Vitellogenins are lipid-binding proteins
that are produced in the intestine, secreted as yolk into the
body cavity, and diffused into the gonad, where they are endocy-
tosed by developing oocytes (Grant and Hirsh, 1999; Kimble
and Sharrock, 1983). We measured the expression of vit genes
in mafr-1 O/E (Figure 2B) and mafr-1 RNAi-treated animals
(Figure 2C) and discovered MAFR-1 negatively regulated the
expression vit-2, vit-4, vit-5, and vit-6. The reduction in vit
expression inmafr-1O/E animals was specific tomafr-1 expres-
sion levels as RNAi targetingmafr-1 could reverse this reduction
(Figure S2A). Next, we tested whether vit gene expression was
tied to the change in organismal tRNA abundance when mafr-1
levels are altered (Figure 1). As reported above, RNAi of tbp-1hors
Figure 2. Impact of mafr-1 Expression on Lipid Transport and
Oocyte Development
(A–C) The vitellogenin lipid transport system was significantly repressed in
microarrays ofmafr-1 O/E animals as compared to nontransgenic siblings (A);
numbers represent fold change in expression as compared to wild-type
animals. qPCR analysis reveals the lipid transport genes vit-2, -4, -5, and -6 are
differentially regulated by mafr-1 levels in mafr-1 O/E (B) or RNAi-treated (C)
animals.
(D) Altered vitellogenin gene expression correlates with localization and
abundance of VIT-2::GFP in developing oocytes.
Scale bars represent 50 mm. See also Figure S2.
Cell Reor brf-1 reduced the expression of tRNAs, similar tomafr-1 O/E.
However, unlike mafr-1 O/E, brf-1 RNAi-treated animals in gen-
eral have normal levels of vit expression (Figure S2B). Surpris-
ingly, animals with reduced expression of tbp-1 actually increase
vit gene expression (Figure S2B). Taken together these findings
implicate a role for MAFR-1 in the expression of vit genes that is
not simply a result of altered transcription of tRNAs.
To further examine the effects of mafr-1 expression on VIT-2
function, we utilized a transgenic strain expressing a VIT-2 fusion
to GFP to allow visualization of lipid transport to the reproductive
system (Grant and Hirsh, 1999). Consistent with our gene
expression analysis, oocytes in mafr-1 O/E animals contained
less intracellular VIT-2::GFP when compared to controls (Fig-
ure 2D). Similarly, RNAi of mafr-1 led to a modest increase in
VIT-2::GFP in oocytes. These data suggest thatmafr-1 regulates
the expression of the vitellogenin yolk precursor proteins in the
intestine, which function in a cell-nonautonomous manner in
the developing germline of the reproductive system.
We hypothesized that the diminished abundance of VIT-2 lipid
particles in the developing oocytes ofmafr-1 O/E animals would
result in a strong reproduction phenotype. As predicted, mafr-1
O/E animals display a >50% reduction in fecundity as compared
to wild-type controls (Figure 3A). In addition, mafr-1 O/E had
no measurable effect on embryo viability as all eggs hatched
(Figure 3B). The diminished reproduction phenotype is tied
to MAFR-1 overexpression as RNAi of mafr-1 in the mafr-1 O/E
strain could partially restore progeny production (Figure 3C).
Intriguingly, in wild-type animals, RNAi of mafr-1 was not
capable of increasing total brood size (Figure S3A). brf-1 RNAi
animals have a small reduction in fecundity that is synergistically
reduced when combined with mafr-1 O/E, which suggests two
parallel pathways converging upon reproductive output (Fig-
ure S3B). This finding is consistent with our observation that
the altered expression of vit genes in themafr-1 O/E strain could
not be phenocopied by simply reducing the expression of RNA
Pol III transcripts following tbp-1 or brf-1 RNAi. We could not
test the relationship with tbp-1 in this assay as tbp-1 RNAi treat-
ment in worms leads to embryonic lethality (Go¨nczy et al., 2000;
Piano et al., 2000).
Since vitellogenesis occurs in the intestine, we next tested
whethermafr-1 expression specifically in the intestinewascausal
for the observed decline in reproductive output. The intestinal-
specific RNAi strain has a reduced brood as compared to wild-
type animals, which is perhaps due to the sid-1(qt9) genetic
background compounded with the intestinal sid-1(+) rescue
array. However,mafr-1O/E is still capable of reducing fecundity,
demonstrating that reproductive output in this strain remains
sensitive to mafr-1 levels. Importantly, when we lower mafr-1
expression by RNAi specifically in the intestine of animals with
mafr-1 O/E, we observed an increase in fecundity (Figures 3D
andS3C). Together, these results suggest thatmafr-1 expression
exerts a cell-nonautonomous influence on reproductive success
by altering lipid transport and not through pleiotropic effects on
zygote formation or embryonic development (Figure 3E).
mafr-1 Negatively Regulates Lipid Homeostasis
Our microarray analysis of mafr-1 overexpression animals
identified a significant enrichment for lipid, amino acid, andports 9, 2180–2191, December 24, 2014 ª2014 The Authors 2183
Figure 3. Altered mafr-1 Expression in the
Intestine Has Cell-Nonautonomous Effects
on Reproductive Output
(A and B) Total brood size (A) and embryo viability
(B) of animals with mafr-1 O/E.
(C and D) Restoration of fecundity by tissue gen-
eral (C) or intestine-specific (D) RNAi of mafr-1.
(E) Model for cell-nonautonomous role of mafr-1
expression on fecundity.
Data are presented as mean ± SEM. *p < 0.05,
**p < 0.01, ***p < 0.001 versus respective controls.
See also Figure S3.carbohydrate metabolism genes (Figure 4A). We examined the
expression of established lipid metabolism genes in mafr-1
single-copy overexpression and mafr-1 RNAi-treated animals
(Figures 4B and 4C). We increased the specificity of our mafr-1
sensitive gene targets by imposing a requirement for reciprocal
effects on transcript levels: increased expression in mafr-1
RNAi animals and decreased expression in mafr-1 O/E animals.
The enrichment for lipid metabolism genes was intriguing, but
maintenance of lipid homeostasis requires the coordination of
hundreds of lipid pathway genes. As such, we first focused on
lipid biosynthesis. The expression of the C. elegans lipid biosyn-
thesis genes pod-2/ACC1 and fasn-1/FASN were repressed in
mafr-1 O/E animals (Figure 4B) and higher when mafr-1 expres-
sion was reduced by RNAi (Figure 4C). The repression in mafr-1
O/E could be reversed by mafr-1 RNAi (Figure S4A). Similar to
our findings for the expression of the vit genes, pod-2 and
fasn-1 transcript levels were not altered in brf-1 RNAi animals
and were increased in tbp-1 RNAi-treated worms (Figure S4B).
This is suggestive that the changes in the expression of lipid
biosynthesis genes in mafr-1 O/E animals are not simply a
response to global reduction in tRNA biosynthesis or tbp-1
expression. We also examined the expression of multiple lipid
homeostasis genes that function in fatty acid oxidation and lipol-
ysis, but could not detect any significant change when mafr-1
was reduced by RNAi or overexpressed (Figures S4C and2184 Cell Reports 9, 2180–2191, December 24, 2014 ª2014 The AuthorsS4D). Together these results reveal that
MAFR-1 regulates intracellular lipids in
part through its ability to regulate lipo-
genic enzyme gene expression.
Previous studies on Maf1 function
have primarily focused on single-cell
models (Boguta, 2013; Johnson et al.,
2007; Michels et al., 2010; Rohira et al.,
2013; Shor et al., 2010). The observed
changes in lipid homeostasis resulting
from altering mafr-1 in the entire organ-
ism can result from cell-autonomous
and/or cell-nonautonomous effects on
physiology. The GO terms enriched in
animals with altered mafr-1 expression
included genes expressed in a variety of
tissues, which may act in an autonomous
manner. Because our microarray analysis
is a snapshot of expression of all tissuesin the animal combined, we took advantage of the conserved
activity of MAFR-1 in mammalian cells and asked if MAFR-1
could also alter the expression of de novo lipogenesis genes
in this model. Similar to our observations for RNA Pol III gene
targets, 293T cells overexpressing either MAFR-1 or human
Maf1 have lower levels of human ACC1 and FASN mRNAs
(Figure 4D).
The enrichment for metabolism genes in our microarrays
prompted an investigation of the biological relevance of
mafr-1 expression on metabolic homeostasis. Similar to most
animals, C. elegans fat homeostasis is influenced by multiple
metabolic pathways (Mak, 2012). As such, we first examined
the levels of stored fat by fixed Nile red and Oil red O staining
in mafr-1 O/E and mafr-1 RNAi animals. Overexpression of
mafr-1 led to a significant 35% reduction of intracellular lipids
(Figures 4E and 4F; Figure S4F), while RNAi of mafr-1 resulted
in a striking 94% increase in stored intestinal fat (Figures 4G,
4H, and S4E). Similar to previous reports, we found the steady
state levels of stored lipids to be lower in worms fed RNAi bac-
teria HT115 as compared to OP50 (Figures 4E, 4G, S4G, and
S4H). Importantly, the changes in stored fat were not a result
of altered food intake, as measured by pharyngeal pumping
rates (Figure S4I). These results indicate that organismal lipid
homeostasis is sensitive to even single-copy variations in
mafr-1 expression.
MAFR-1 Is Regulated by Glucose and Insulin Signaling
The measured reduction in stored lipids observed in animals
overexpressing mafr-1 led us to test if mafr-1 O/E could coun-
teract diet-induced obesity in the C. elegans model. To this
end, we challenged mafr-1 O/E animals on a high carbohydrate
diet (HCD), which is capable of inducing increased storage of
intracellular lipids (Lee et al., 2009; Pang and Curran, 2014;
Pang et al., 2014; Schulz et al., 2007) (Figures 5A and 5B).
Consistent with the steady state reduction in stored lipids on a
normal diet, mafr-1 O/E could partially reduce the accumulation
of lipids on the HCD by 10%, albeit these animals were still
significantly more fat than animals raised on a normal diet. In
fact, because the mafr-1 O/E animals are less fat than wild-
type on a regular diet, the increase (166%) when mafr-1 O/E
animals are fed a HCD compared to a regular diet is much larger
than the increase (112%) observed in wild-type animals on
similar diets (Figure 5B).
In the presence of ample dietary sugars, excess carbohy-
drates are converted to triglycerides (Hillgartner et al., 1995).
The ability of mafr-1 levels to alter de novo lipogenesis, but not
effectively abrogate the total lipid increase on a HCD suggested
mafr-1 itself, could be sensitive to nutrient availability. To test
this, we first examined the levels of MAFR-1::GFP in animals
fed a HCD. MAFR-1 protein was reduced in animals raised in
the presence of glucose (Figure 5C). The reduction in MAFR-1
was in part the result of reduced expression of mafr-1 on the
HCD, both in wild-type and MAFR-1::GFP expressing animals
(Figure 5D). This diet-induced repression effectively abrogates
the increased expression of mafr-1 in mafr-1 O/E animals when
glucose is present. Previous biochemical characterization of
the Escherichia coli strains OP50 and HT115 have revealed
that the HT115 diet has a higher carbohydrate composition
than OP50 (Brooks et al., 2009). Consistent with these findings,
a comparison of the mafr-1 levels in animals raised on these
two diets reveals lower expression of mafr-1 when fed the
HT115 diet (Figure S5A). These data indicate mafr-1 expression
and MAFR-1 protein levels are sensitive to the abundance of
dietary carbohydrates.
In C. elegans, the presence of glucose represses the FoxO
transcription factor DAF-16 (Lee et al., 2009) through a
conserved insulin/IGF-like signaling pathway. We tested
whether inhibition of DAF-16/FoxO activity was sufficient to sup-
press the effects ofmafr-1 expression levels using animals lack-
ing the DAF-16 regulator daf-18/PTEN. In the absence of daf-18/
PTEN, the insulin signaling pathway is derepressed and DAF-16
activity is inhibited (Ogg and Ruvkun, 1998). In this genetic
background, the induced changes in stored lipids mediated by
mafr-1 overexpression (Figures 5E and S5B) or RNAi reduction
(Figures 5F and S5C) were abrogated. In addition, we tested
the ability of mafr-1 expression levels to alter intracellular lipid
homeostasis in the absence of daf-16. The mafr-1-dependent
change in steady state levels of intracellular lipids was abolished
in the absence of DAF-16/FoxO (Figures 5E, 5F, S5B, and S5C).
These data reveal a requirement for the insulin-like signaling
pathway in MAFR-1 mediated regulation of stored lipids. This
finding is consistent with the reported role for the insulin recep-
tor acting downstream of dMaf1 in regulating growth in flies (Ri-
deout et al., 2012).Cell ReWe further investigated why these daf-16 null mutants were
insensitive to mafr-1 O/E. The requirement of DAF-16 in the
MAFR-1 lipid phenotype could result from transcriptional
regulation ofmafr-1.Wemeasuredmafr-1 expression in animals
lacking daf-16 and found a 50% reduction in expression as
compared to wild-type animals (Figures 5G and 5H). Next, we
looked at the requirement of DAF-16 in the induction of tRNAs,
vit, and lipid biosynthesis genes when mafr-1 expression was
reduced by RNAi. In the absence of daf-16,mafr-1 RNAi was still
able to induce the expression of most tRNAs, although the basal
expression of multiple tRNAs was initially lower in the daf-
16(mu86) null mutant background as compared to wild-type
controls. mafr-1 RNAi was similarly able to increase the expres-
sion of pod-2/ACC1, vit-2, -4, and -5 but, intriguingly, not fasn-1
and vit-6 (Figure S5D).
In flies, inhibition of dMaf1 by RNAi results in the release of
insulin-like peptides and systemic insulin signaling. We therefore
tested whether mafr-1 had a similar effect on insulin-like
signaling in C. elegans. We equated activation of insulin-like
signaling by measuring the induction of the DAF-16/FoxO target
gene sod-3. Unlike the effect of the hypomorphic allele of the
insulin-like receptor, daf-2(e1368), which leads to a dramatic
60-fold increase in the expression of sod-3, overexpression
of mafr-1 led to a small but significant 2.5-fold increase in
sod-3 expression (Figure S5E). Feedback and feed-forward
regulation by endocrine systems are well established (Murphy
and Hu, 2013; Rutter, 1999), and our data are consistent with
previous reports that insulin/IGF-I signaling can potentiate
organismal responses to Maf1 (Rideout et al., 2012). Future
dissection of where and how MAFR-1 integrates into the insu-
lin-like signaling pathway will be of great interest.
DISCUSSION
We have identified C. elegansMAFR-1 as the functional ortholog
ofmammalianMaf1 and uncovered roles forMAFR-1 in the regu-
lation of organismal fecundity and lipid homeostasis (Figure 6).
We find that MAFR-1 can function in an orthologous manner
to human Maf1 (hMaf1) in cell culture. Specifically, we find that
MAFR-1 is capable of repressing the expression of human
RNA Pol III transcribed targets, which indicates functional con-
servation between invertebrates and mammals. Moreover,
MAFR-1 can alter the transcript levels of RNA Pol II targets
such as tbp-1, similar to mammalian Maf1 (Johnson et al.,
2007). tbp-1 RNAi reduces tRNA transcript levels in a manner
similar to the effect observed inmafr-1 O/E. However, the reduc-
tion in tbp-1 expression is not solely responsible for all of the
physiological responses we have documented, as tbp-1 RNAi
fails to phenocopy themafr-1O/E strain. This finding is intriguing,
especially in light of the increased expression of the vit genes
observed in tbp-1RNAi-treated animals. TheC. elegans genome
encodes one TBP-related factor, tlf-1, which could possibly
compensate for the absence of tbp-1. We find that although
tbp-1 levels are responsive to mafr-1, tlf-1 levels are not altered
when mafr-1 is reduced or overexpressed (Figure S1F). Intrigu-
ingly, tlf-1 levels are also lower in tbp-1 RNAi-treated animals
and, therefore, not likely compensating for tbp-1 (Figure S1F).
This is consistent with previous studies that suggest TLF-1ports 9, 2180–2191, December 24, 2014 ª2014 The Authors 2185
(legend on next page)
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performs a unique function in activating bulk RNA Pol II tran-
scription during embryogenesis that is distinct from TBP-1 (Kal-
tenbach et al., 2000).
Our studies uncover the finding that Maf1 regulates intracel-
lular lipids. The transcriptional and physiological effects of
alteringmafr-1 abundance are specific tomafr-1, as we can sup-
press the observed changes in the mafr-1 O/E strain with RNAi
knockdown of mafr-1. An examination of the mechanism by
which this occurs reveals that Maf1 represses the expression
of lipid biosynthesis (pod-2 and fasn-1) and transport (vit) genes.
The changes observed in lipid biosynthesis genes and vitelloge-
nins are not simply due to changes in RNAPol III transcription, as
directly altering RNA Pol III-dependent transcription does not
change the expression of these RNA Pol II-transcribed genes.
Although 293T cell have abnormal metabolism, our findings are
further supported by complementary chromatin immunoprecip-
itation studies from Deborah Johnson’s group showing hMaf1
occupies the FASN promoter and regulates intracellular lipid
abundance in Huh7 cells, whose lipid metabolism and physi-
ology are more clearly defined than 293T cells (Palian et al.,
2014). Although this does not exclude the possibility that Maf1
may participate in other pathways to regulate lipid homeostasis,
we identify Maf1 as an important negative regulator of lipid
biogenesis.
Excess dietary carbohydrate added to the growthmedium can
increase lipids and decrease survival (Lee et al., 2009). Although
carbohydrates represent just onemajormacronutrient difference
between the OP50 and HT115 diets, our data reveal a role
for MAFR-1 in metabolic homeostasis and that C. elegans lipid
metabolism is sensitive to even small changes inmafr-1 expres-
sion.Multiple genetic phenotypes have been shown to onlyman-
ifest on either the OP50 or HT115 diet. Our understanding of the
underlying molecular mechanisms regulating these differences
is only beginning to emerge (Maier et al., 2010; Pang and Curran,
2014; Pang et al., 2014). Under our standard laboratory growth
conditions, the expression of key lipid biosynthesis genes, but
not fatty acid oxidation genes, is repressed by mafr-1, and we
have found that endogenous mafr-1 levels are regulated in part
by available dietary carbohydrates. These two findings could
be functionally linked, as lipid biosynthesis is also regulated
by carbohydrate availability. As such, MAFR-1 could play an in-
tegral role in fine-tuning this pathway, which ultimately impacts
steady state levels of stored intracellular lipids. Importantly,
these results define additional layers of specificity of the
MAFR-1 biologically relevant pathways, as we do not observe
deregulation in the expression of all genes when mafr-1 levels
are deregulated.
The ability of an organism to integrate information on available
nutrients to coordinate growth and metabolism is essential forFigure 4. mafr-1 Expression Levels Alter Organismal Lipid Homeostas
(A) Multiple GO terms tied to cellular metabolism were significantly repressed in
(B and C) Expression of the lipid biosynthesis genes pod-2/ACC1 and fasn-1/FA
(D) Expression of human ACC and FASN in human 293T cells transfected with e
(E and F) Nile red staining of OP50 fed wild-type and mafr-1 O/E animals. The re
(G and H) Nile red staining of wild-type animals fed control or mafr-1 RNAi bacte
Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 versus
condition. Scale bars represent 200 mm. See also Figure S4.
Cell Resurvival (Mair, 2013; Pang and Curran, 2014; Pang et al., 2014).
We find that the levels of MAFR-1 are influenced by the abun-
dance of nutritional glucose and that mafr-1 expression is lower
in animals fed an E. coli K-12 HT115 diet versus the standard
E. coli B OP50 diet. Intriguingly, the observed reduction in
expression on these two diets may involve the insulin-signaling
pathway, as the expression of mafr-1 in the absence of daf-16/
FoxO is similar on either food source. This finding is correlative
with previous characterization of these bacterial strains, which
revealed a 3- to 5-fold higher level of endogenous carbohydrates
in HT115 bacteria (Brooks et al., 2009). We also noted a trend for
a slightly larger brood size in wild-type animals fed the HT115
diet, but the inability for mafr-1 RNAi to further increase this
brood. These results are consistent with the lower expression
of mafr-1 on the HT115 diet and suggest that further reduction
of mafr-1 cannot synergistically enhance reproductive capacity,
whose maximum is dictated by spermatogenesis (Hughes et al.,
2007; Ward and Carrel, 1979). Obviously the use of bacteria as a
food source increases the complexity of deciphering diet-
dependent phenotypes, particularly when additives such of
glucose are utilized, which can alter bacterial growth and
physiology. Although animals feeding on the HT115 diet do not
show an increase in stored fat, despite diminished mafr-1
expression, this could be the result of a variety of metabolic
actions initiated by the host in response to this complex diet
(Brooks et al., 2009). The identification of other specific macro-
nutrient triggers will be needed to determine the extent to which
MAFR-1 integrates into other metabolic pathways.
The reduction in total cellular fat accumulation whenmafr-1 is
overexpressed in worms is intriguing and suggests that mafr-1
could be a potential target for therapies of obesity andmetabolic
diseases. Although our worm model of mafr-1 overexpression
when fed a HCD was statistically less fat than wild-type animals
fed the same diet, the percent increase in fat as compared to
the same animals on a normal diet was greater for the mafr-1
O/E strain. This could be due to the fact that our overexpression
system is a result of a single additional copy of mafr-1. Future
studies will investigate if higher gene dosages can provide
additional protection from a HCD and if manipulating mafr-1
specifically in the intestine can cell autonomously impact lipid
metabolism.
We also identify DAF-16/FoxO as a genetic regulator ofmafr-1
expression. However, the strong reduction in MAFR-1 protein
levels on the HCD can only partially be explained by changes
in mafr-1 expression. Whether DAF-16 directly regulates the
transcription ofmafr-1 remains to be elucidated. A bioinformatic
investigation of themafr-1 promoter reveals a canonical DAF-16
associated element binding site at766 nt from the translational
start site (Murphy et al., 2003). An unbiased chromatinis
microarrays of mafr-1 O/E animals as compared to nontransgenic siblings.
SN in animals overexpressing mafr-1 (B) or with RNAi-reduction of mafr-1 (C).
ither MAFR-1 or hMaf1 constructs.
presentative animals (E) and quantitative data (F) are shown.
ria. The representative images (G) and quantitative data (H) are shown.
respective controls; n, number of animals used for statistical analysis in each
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Figure 5. Glucose and Insulin Signaling Pathways Regulate the Expression of mafr-1
(A andB)Nile redstaining ofwormswith indicatedgenotypes fedOP50orOP50plus 2%glucose. The representative images (A) andquantitative data (B) are shown.
(C and D) Dietary glucose reduces the steady state levels of MAFR-1 protein (C) and mafr-1 transcripts (D).
(E and F) Quantification of Nile red staining of animals overexpressing mafr-1 (E) or RNAi treated for mafr-1 (F) in daf-18/PTEN or daf-16/FoxO mutant
backgrounds.
(G and H) Expression of mafr-1 in daf-16/FoxO RNAi-treated (G) or genetic null mutant (H) animals.
Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 versus respective controls; n, number of animals used for statistical analysis in each
condition. Scale bars represent 600 mm. See also Figure S5.immunoprecipitation sequencing screen by the modENCODE
project identified DAF-16::GFP associated with themafr-1 locus,
near a noncanonical DAF-16 binding element (Gerstein et al.,
2010) (Figure S5F), which suggests DAF-16/FoxO could indeed2188 Cell Reports 9, 2180–2191, December 24, 2014 ª2014 The Autregulate mafr-1. Collectively, our studies have uncovered roles
for the conserved protein MAFR-1 in the maintenance of repro-
duction and lipid homeostasis, which genetically engage the in-
sulin signaling effector protein DAF-16/FoxO (Figure 6).hors
Figure 6. Model of the Central Role of MAFR-1 in Organismal
Physiology
MAFR-1 can influence animal physiology in both an insulin/FoxO-dependent
(orange) and -independent (blue) manner. Alteredmafr-1 levels in the intestine
cell nonautonomously impacts fecundity through changes in the production of
the vitellogenin family of proteins that deregulates lipid transport to developing
oocytes in the germline. Black arrows and bars indicate genetic interactions.
DAF-16/FoxO may directly regulate the expression of mafr-1 (dashed red ar-
row). Other factors that regulate DAF-16/FoxO-dependent and independent
regulation of Maf1 may exist (?) and influence Maf1 cell autonomously and
nonautonomously. Dashed cell boundary indicates potential autocrine, para-
crine, or endocrine signals resulting from Maf1 activity.Lipid transport within a multicellular organism is facilitated by
lipoproteins that emulsify lipids and allow these fats to move
through aqueous environments. Vitellogenesis is a hormonally
controlled and conserved process in birds, reptiles, fish, and
many invertebrates that generate yolk as a nutrient source
for early embryogenesis (Schneider, 1996). We have discov-
ered thatmafr-1 levels influence vitellogenin production. Animals
overexpressing mafr-1 have reduced expression of vit-2, -4, -5,
and -6 and developing oocytes contain less VIT-2 protein, as
measured by a VIT-2::GFP fusion protein. As such, the change
in mafr-1 expression, which leads to a change in the intestinal
expression of vitellogenins, exerts a cell-nonautonomous influ-
ence on oocyte maturation in the germline.
A second physiological consequence uncovered from altered
mafr-1 expression is a change in organismal reproductive ca-
pacity. Fecundity is under both genetic and environmental con-
trol, and we identify mafr-1 as a central player in this essential
biological process. MAFR-1 levels are continually reduced and
settle to their lowest point at the peak of germ cell development.Cell ReThe reduction of MAFR-1 levels during the maturation of the
reproductive system could be of functional relevance since
animals with increased mafr-1 expression have reduced egg
production. This reduced fecundity correlates with deregulated
vitellogenin synthesis and localization, which is essential for
oocyte maturation. Previous studies have found that the vit
genes are transcribed in excess in the intestine and can be
titrated to cope with reproduction demands (DePina et al.,
2011). As such, increases in yolk synthesis would not necessarily
increase fecundity, as we found, but in the context of low yolk
availability, such as in the mafr-1 overexpression lines, the
increased production of vitellogenins following mafr-1 RNAi
can partially restore embryo development. The use of whole-or-
ganismmicroarray and quantitative PCR (qPCR) analysis of gene
expression can confound the extrapolation of cell-autonomous
versus cell-nonautonomous effects. Thus, it remains possible
that pod-2/ACC1 and fasn-1/FASN expression in the germline
may have important roles in fecundity. Nevertheless, the fact
that the vit family of genes is expressed specifically in the intes-
tine and our finding that intestine-specific regulation of mafr-1
levels can alter reproductive output provides evidence for
mafr-1 in the intestine exerting a cell-nonautonomous effect on
the reproductive system. Further dissection of the cell-autono-
mous and cell-nonautonomous mechanisms that mediate
Maf1 function on the organism level will be of future interest.
Investigating the differences in the regulation of and the
physiological responses to Maf1 across species is of particular
interest. Similar to dMaf1, altering the expression of mafr-1, in
a tissue-specific manner can have significant impact at the or-
ganism level (Rideout et al., 2012). mafr-1 expression does not
appear to influence developmental timing, as dMaf1 does in flies,
although it can modestly impact organismal growth. While the
physiological response from altering mafr-1 expression does
not appear to influence the insulin/IGF-I signaling pathway as
potently as it does in flies, we nevertheless find a partial require-
ment for DAF-16/FoxO in mediating these mafr-1-sensitive
physiological parameters. Moreover, daf-16/FoxO was dispens-
able for the mafr-1-dependent changes to tRNA genes. This is
consistent with the idea that the insulin/IGF-I signaling pathway
functions downstream ofmafr-1, as it has been described in flies
(Figure 6). Our results emphasize the importance of examining
the role of central cellular regulators in the context of a multicel-
lular system, which has led to the identification of physiological
roles for Maf1 in reproduction and lipid metabolism. Defining
the tissues and cells where insulin signaling participates, either
cell autonomously and/or nonautonomously, in the mafr-1-
dependent phenotypes we have described will be important to
further refine our model.
Aside from developmental timing, there are intriguing differ-
ences between the biological role of Maf1 in flies and worms.
In flies, dMaf1 RNAi can impact the expression of iMet, Ile, and
Leu tRNAs, while dMaf1 overexpression had no effect (Rideout
et al., 2012). In worms, we find that increasedmafr-1 expression
decreased the abundance of all tRNA species tested andmafr-1
RNAi led to the increased expression of 11 out of 13 of these
tRNAs (Figures 1A, 1B, S1A, and S1B). Second, in flies, dMaf1
and the RNA Pol III factor Brf1, which controls tRNA biosyn-
thesis, are tied to the growth and developmental timingports 9, 2180–2191, December 24, 2014 ª2014 The Authors 2189
phenotypes (Marshall et al., 2012). In worms, brf-1 and mafr-1
can both regulate tRNA transcript levels; however, the lipid
homeostasis phenotypes observed in the mafr-1 O/E strains
cannot be phenocopied by reduction of brf-1 expression. These
data implicate a role for MAFR-1 beyond modulating RNA Pol III
transcript levels. Third, although dMaf1 expression in the fat
body was found to be key to its function, it remains unknown
whether dMaf1 can influence fat accumulation or reproduction,
which are two physiological process intimately linked to
signaling from the fly fat body (Arrese and Soulages, 2010). While
there will certainly be indirect effects resulting from homeostatic
responses to the changes in RNA Pol III transcript levels and/or
possible positional effects due to the chromosomal proximity
of RNA Pol III and Pol II targets (Hull et al., 1994; Kinsey and
Sandmeyer, 1991), defining the molecular mechanisms underly-
ing Maf1 function will be critical to understanding the physiolog-
ical differences observed in flies, worms, and mammals.
EXPERIMENTAL PROCEDURES
Standard Growth Conditions
C. elegans were raised on standard 6 cm nematode growth media plates
supplemented with streptomycin and seeded with E. coli OP50. For RNAi
experiments, nematode growth medium plates containing 5 mM Isopropyl
b-D-1-thiogalactopyranoside and 100 mg ml1 carbencillin were seeded with
overnight cultures of double-stranded RNAi-expressing HT115 bacteria. Plates
were allowed to induce overnight, followed by transfer of age-synchronous
populations ofC. elegans.Animalswere fed either OP50or HT115 food sources
for at least two generations before analysis to avoid diet-dependent effects.
Gene Expression
Developmentally synchronous worms of indicated genotype and develop-
mental stages were collected, washed in M9 buffer, and then homogenized
in Trizol reagent (Invitrogen). RNA was extracted according to manufacturer’s
protocol. DNA contamination was digested with DNase I (New England
Biolabs). cDNA was generated with the SuperScript III First-Strand Synthesis
System (Life Technologies). RNA samples were also used for Affymetrix
C. elegans Gene 1.0 ST Arrays. Data and statistics were analyzed with Partek
Genomics Suite Software version 6.6.
Quantitative PCRwas performedby usingSYBRGreen (BioRad). The expres-
sion of snb-1 was used to normalize C. elegans RNA samples and GAPDH for
human cell culture samples. The efficiencies of all primers used were within
5% of each other. Human RNA Pol III primer sequences were taken from John-
son et al., 2007. Primers for C. elegans genes were designed using the
Primer3Plus algorithm (Untergasser et al., 2012). Primers for C.elegans RNA
Pol III targets were designed using the Genomic tRNA database (Chan and
Lowe, 2009).
Protein Extraction
Wormswerewashed twicewith PBS followed by oncewith PBS supplemented
with protease inhibitors. An equal volume of 2X LDS buffer was added and
worms were flash frozen and thawed at 90 degrees; the cycle was repeated
three times. Crude lysates were passed through a 26G needle and centrifuged
at max speed for 20 min, and supernatants were used for protein analysis.
Staining of Fat
Nile red staining was performed as previously described (Pino et al., 2013).
Briefly, animals of indicated genotypes were collected, fixed in 40% propanol,
and stained in Nile red working solution in dark for 2 hr. Worms were washed
once with PBS/0.01% Triton-X in the dark for 30 min, mounted on slides, and
imaged. Fluorescent density was measured by using NIH ImageJ software.
In brief, images were converted to a 32-bit format, and then the background/
GFP intensity was measured using the Integrated Density (ID) method. The re-
gion of interest tool was used for normalization to body size.2190 Cell Reports 9, 2180–2191, December 24, 2014 ª2014 The AutFor Oil RedO staining, animals were collected and fixed in 1% formaldehyde
in PBS. Then samples were frozen and thawed three times in a dry ice/ethanol
bath. Worms were washed with PBS three times before staining with freshly
prepared Oil Red O solution. After staining for 30 min, worms were washed
for 15 min, mounted on slides, and imaged under a bright field illumination.
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